Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Michael Kamarck
Age : 69
Public asset : 10,271,097 USD
Country of residence : Unknown
Linked companies : Vir Biotechnology, Inc. - Trillium Therapeutics Inc.

Biography of Michael Kamarck 
Currently, Michael E. Kamarck occupies the position of Chief Technology Officer for Vir Biotechnology, Inc. Dr. Kamarck is also on the board of Trillium Therapeutics, Inc. and Unilife Medical Solutions, Inc. and Member of TransForm Pharmaceuticals, Inc. In the past he held the position of SVP-Global Vaccines & Biologics Manufacturing at Merck & Co., Inc. and President of Merck BioVentures (a subsidiary of Merck & Co., Inc.), Head-Therapeutic Monoclonal Antibodies at Sanofi, President-Technical Operations & Product Supply at Wyeth Pharmaceuticals, Inc. and Principal at Willow Creek Biotech Consulting LLC. He received an undergraduate degree from Oberlin College and a doctorate from Massachusetts Institute of Technology.

Current positions of Michael Kamarck 
Holdings of Michael Kamarck 
Michael Kamarck : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
09:11aSTELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
More news

© 2021 People and Ownership :   
Michael Kamarck : Connections 

Latest news about Michael Kamarck 
2020Trillium Therapeutics Inc. Appoints Michael Kamarck to Its Board of Directors, Effective Immediately
More news